EPIDIOLEX
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

EPIDIOLEX Trademark

Serial Number: 79330764 • Registration: 6976396

EPIDIOLEX is a trademark filed by Jazz Pharmaceuticals Research UK Limited on June 23, 2021. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Jazz Pharmaceuticals Research UK Limited (46 trademarks)

Building 730,

Entity Type: 98

GW Research Ltd (2 trademarks)

Sovereign House, Vision Park,

Entity Type: 99

Trademark Details

Filing Date

June 23, 2021

Registration Date

February 14, 2023

Published for Opposition

November 29, 2022

Goods & Services

Scientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, and cancer treatment, and research and design relating thereto; chemical analysis; chemical research; research and development of new products for others; research and development on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; conducting clinical trials in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; information, advisory and consultancy services in relation to all of the aforesaid services

Medical services, veterinary services, medical analysis services; pharmaceutical services; pharmaceutical advisory services; provision of pharmaceutical information; providing information in the field of medicine; horticultural services; information, advisory and consultancy services in relation to all of the aforesaid services

Educational services namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; instruction and training services, in the field of pharmaceutical product development of medicines and cancer treatments; education services relating to medicine, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, and cancer treatment; organising and conducting seminars and conventions in the field of medicine; information, advisory and consultancy services in relation to all of the aforesaid services

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 11, 2025 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 13, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 18, 2023 FICS
FINAL DISPOSITION PROCESSED
May 17, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 14, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 14, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 14, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Dec 12, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 29, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 29, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 23, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 23, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 9, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 13, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 12, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 12, 2022 TROA
REFUSAL PROCESSED BY IB
May 25, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 29, 2022 RFCS
REFUSAL PROCESSED BY MPU
Apr 29, 2022 RFRR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 1, 2022 NREP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 18, 2022 RFCR
NON-FINAL ACTION WRITTEN
Mar 17, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 15, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 1, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 27, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 20, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 6, 2022 REPR